1 Report Overview 1.1 Study Scope 1.2 Market Analysis by Type 1.2.1 Global Biopharmaceutical and Vaccine Production Market Size Growth Rate by Type: 2016 VS 2021 VS 2027 1.2.2 Biopharmaceutical 1.2.3 Vaccine Production 1.3 Market by Application 1.3.1 Global Biopharmaceutical and Vaccine Production Market Share by Application: 2016 VS 2021 VS 2027 1.3.2 Pharmaceutical 1.3.3 Biotechnology 1.3.4 Academic and Research Institutes 1.3.5 Others 1.4 Study Objectives 1.5 Years Considered 2 Global Growth Trends 2.1 Global Biopharmaceutical and Vaccine Production Market Perspective (2016-2027) 2.2 Biopharmaceutical and Vaccine Production Growth Trends by Regions 2.2.1 Biopharmaceutical and Vaccine Production Market Size by Regions: 2016 VS 2021 VS 2027 2.2.2 Biopharmaceutical and Vaccine Production Historic Market Share by Regions (2016-2021) 2.2.3 Biopharmaceutical and Vaccine Production Forecasted Market Size by Regions (2022-2027) 2.3 Biopharmaceutical and Vaccine Production Industry Dynamic 2.3.1 Biopharmaceutical and Vaccine Production Market Trends 2.3.2 Biopharmaceutical and Vaccine Production Market Drivers 2.3.3 Biopharmaceutical and Vaccine Production Market Challenges 2.3.4 Biopharmaceutical and Vaccine Production Market Restraints 3 Competition Landscape by Key Players 3.1 Global Top Biopharmaceutical and Vaccine Production Players by Revenue 3.1.1 Global Top Biopharmaceutical and Vaccine Production Players by Revenue (2016-2021) 3.1.2 Global Biopharmaceutical and Vaccine Production Revenue Market Share by Players (2016-2021) 3.2 Global Biopharmaceutical and Vaccine Production Market Share by Company Type (Tier 1, Tier 2 and Tier 3) 3.3 Players Covered: Ranking by Biopharmaceutical and Vaccine Production Revenue 3.4 Global Biopharmaceutical and Vaccine Production Market Concentration Ratio 3.4.1 Global Biopharmaceutical and Vaccine Production Market Concentration Ratio (CR5 and HHI) 3.4.2 Global Top 10 and Top 5 Companies by Biopharmaceutical and Vaccine Production Revenue in 2020 3.5 Biopharmaceutical and Vaccine Production Key Players Head office and Area Served 3.6 Key Players Biopharmaceutical and Vaccine Production Product Solution and Service 3.7 Date of Enter into Biopharmaceutical and Vaccine Production Market 3.8 Mergers & Acquisitions, Expansion Plans 4 Biopharmaceutical and Vaccine Production Breakdown Data by Type 4.1 Global Biopharmaceutical and Vaccine Production Historic Market Size by Type (2016-2021) 4.2 Global Biopharmaceutical and Vaccine Production Forecasted Market Size by Type (2022-2027) 5 Biopharmaceutical and Vaccine Production Breakdown Data by Application 5.1 Global Biopharmaceutical and Vaccine Production Historic Market Size by Application (2016-2021) 5.2 Global Biopharmaceutical and Vaccine Production Forecasted Market Size by Application (2022-2027) 6 North America 6.1 North America Biopharmaceutical and Vaccine Production Market Size (2016-2027) 6.2 North America Biopharmaceutical and Vaccine Production Market Size by Type 6.2.1 North America Biopharmaceutical and Vaccine Production Market Size by Type (2016-2021) 6.2.2 North America Biopharmaceutical and Vaccine Production Market Size by Type (2022-2027) 6.2.3 North America Biopharmaceutical and Vaccine Production Market Size by Type (2016-2027) 6.3 North America Biopharmaceutical and Vaccine Production Market Size by Application 6.3.1 North America Biopharmaceutical and Vaccine Production Market Size by Application (2016-2021) 6.3.2 North America Biopharmaceutical and Vaccine Production Market Size by Application (2022-2027) 6.3.3 North America Biopharmaceutical and Vaccine Production Market Size by Application (2016-2027) 6.4 North America Biopharmaceutical and Vaccine Production Market Size by Country 6.4.1 North America Biopharmaceutical and Vaccine Production Market Size by Country (2016-2021) 6.4.2 North America Biopharmaceutical and Vaccine Production Market Size by Country (2022-2027) 6.4.3 United States 6.4.3 Canada 7 Europe 7.1 Europe Biopharmaceutical and Vaccine Production Market Size (2016-2027) 7.2 Europe Biopharmaceutical and Vaccine Production Market Size by Type 7.2.1 Europe Biopharmaceutical and Vaccine Production Market Size by Type (2016-2021) 7.2.2 Europe Biopharmaceutical and Vaccine Production Market Size by Type (2022-2027) 7.2.3 Europe Biopharmaceutical and Vaccine Production Market Size by Type (2016-2027) 7.3 Europe Biopharmaceutical and Vaccine Production Market Size by Application 7.3.1 Europe Biopharmaceutical and Vaccine Production Market Size by Application (2016-2021) 7.3.2 Europe Biopharmaceutical and Vaccine Production Market Size by Application (2022-2027) 7.3.3 Europe Biopharmaceutical and Vaccine Production Market Size by Application (2016-2027) 7.4 Europe Biopharmaceutical and Vaccine Production Market Size by Country 7.4.1 Europe Biopharmaceutical and Vaccine Production Market Size by Country (2016-2021) 7.4.2 Europe Biopharmaceutical and Vaccine Production Market Size by Country (2022-2027) 7.4.3 Germany 7.4.4 France 7.4.5 U.K. 7.4.6 Italy 7.4.7 Russia 7.4.8 Nordic 8 Asia-Pacific 8.1 Asia-Pacific Biopharmaceutical and Vaccine Production Market Size (2016-2027) 8.2 Asia-Pacific Biopharmaceutical and Vaccine Production Market Size by Type 8.2.1 Asia-Pacific Biopharmaceutical and Vaccine Production Market Size by Type (2016-2021) 8.2.2 Asia-Pacific Biopharmaceutical and Vaccine Production Market Size by Type (2022-2027) 8.2.3 Asia-Pacific Biopharmaceutical and Vaccine Production Market Size by Type (2016-2027) 8.3 Asia-Pacific Biopharmaceutical and Vaccine Production Market Size by Application 8.3.1 Asia-Pacific Biopharmaceutical and Vaccine Production Market Size by Application (2016-2021) 8.3.2 Asia-Pacific Biopharmaceutical and Vaccine Production Market Size by Application (2022-2027) 8.3.3 Asia-Pacific Biopharmaceutical and Vaccine Production Market Size by Application (2016-2027) 8.4 Asia-Pacific Biopharmaceutical and Vaccine Production Market Size by Region 8.4.1 Asia-Pacific Biopharmaceutical and Vaccine Production Market Size by Region (2016-2021) 8.4.2 Asia-Pacific Biopharmaceutical and Vaccine Production Market Size by Region (2022-2027) 8.4.3 China 8.4.4 Japan 8.4.5 South Korea 8.4.6 Southeast Asia 8.4.7 India 8.4.8 Australia 9 Latin America 9.1 Latin America Biopharmaceutical and Vaccine Production Market Size (2016-2027) 9.2 Latin America Biopharmaceutical and Vaccine Production Market Size by Type 9.2.1 Latin America Biopharmaceutical and Vaccine Production Market Size by Type (2016-2021) 9.2.2 Latin America Biopharmaceutical and Vaccine Production Market Size by Type (2022-2027) 9.2.3 Latin America Biopharmaceutical and Vaccine Production Market Size by Type (2016-2027) 9.3 Latin America Biopharmaceutical and Vaccine Production Market Size by Application 9.3.1 Latin America Biopharmaceutical and Vaccine Production Market Size by Application (2016-2021) 9.3.2 Latin America Biopharmaceutical and Vaccine Production Market Size by Application (2022-2027) 9.3.3 Latin America Biopharmaceutical and Vaccine Production Market Size by Application (2016-2027) 9.4 Latin America Biopharmaceutical and Vaccine Production Market Size by Country 9.4.1 Latin America Biopharmaceutical and Vaccine Production Market Size by Country (2016-2021) 9.4.2 Latin America Biopharmaceutical and Vaccine Production Market Size by Country (2022-2027) 9.4.3 Mexico 9.4.4 Brazil 10 Middle East & Africa 10.1 Middle East & Africa Biopharmaceutical and Vaccine Production Market Size (2016-2027) 10.2 Middle East & Africa Biopharmaceutical and Vaccine Production Market Size by Type 10.2.1 Middle East & Africa Biopharmaceutical and Vaccine Production Market Size by Type (2016-2021) 10.2.2 Middle East & Africa Biopharmaceutical and Vaccine Production Market Size by Type (2022-2027) 10.2.3 Middle East & Africa Biopharmaceutical and Vaccine Production Market Size by Type (2016-2027) 10.3 Middle East & Africa Biopharmaceutical and Vaccine Production Market Size by Application 10.3.1 Middle East & Africa Biopharmaceutical and Vaccine Production Market Size by Application (2016-2021) 10.3.2 Middle East & Africa Biopharmaceutical and Vaccine Production Market Size by Application (2022-2027) 10.3.3 Middle East & Africa Biopharmaceutical and Vaccine Production Market Size by Application (2016-2027) 10.4 Middle East & Africa Biopharmaceutical and Vaccine Production Market Size by Country 10.4.1 Middle East & Africa Biopharmaceutical and Vaccine Production Market Size by Country (2016-2021) 10.4.2 Middle East & Africa Biopharmaceutical and Vaccine Production Market Size by Country (2022-2027) 10.4.3 Turkey 10.4.4 Saudi Arabia 10.4.5 UAE 11 Key Players Profiles 11.1 Novartis 11.1.1 Novartis Company Details 11.1.2 Novartis Business Overview 11.1.3 Novartis Biopharmaceutical and Vaccine Production Introduction 11.1.4 Novartis Revenue in Biopharmaceutical and Vaccine Production Business (2016-2021) 11.1.5 Novartis Recent Development 11.2 Pfizer 11.2.1 Pfizer Company Details 11.2.2 Pfizer Business Overview 11.2.3 Pfizer Biopharmaceutical and Vaccine Production Introduction 11.2.4 Pfizer Revenue in Biopharmaceutical and Vaccine Production Business (2016-2021) 11.2.5 Pfizer Recent Development 11.3 Sanofi 11.3.1 Sanofi Company Details 11.3.2 Sanofi Business Overview 11.3.3 Sanofi Biopharmaceutical and Vaccine Production Introduction 11.3.4 Sanofi Revenue in Biopharmaceutical and Vaccine Production Business (2016-2021) 11.3.5 Sanofi Recent Development 11.4 Roche 11.4.1 Roche Company Details 11.4.2 Roche Business Overview 11.4.3 Roche Biopharmaceutical and Vaccine Production Introduction 11.4.4 Roche Revenue in Biopharmaceutical and Vaccine Production Business (2016-2021) 11.4.5 Roche Recent Development 11.5 Abbott 11.5.1 Abbott Company Details 11.5.2 Abbott Business Overview 11.5.3 Abbott Biopharmaceutical and Vaccine Production Introduction 11.5.4 Abbott Revenue in Biopharmaceutical and Vaccine Production Business (2016-2021) 11.5.5 Abbott Recent Development 11.6 Regeneron Pharmaceuticals 11.6.1 Regeneron Pharmaceuticals Company Details 11.6.2 Regeneron Pharmaceuticals Business Overview 11.6.3 Regeneron Pharmaceuticals Biopharmaceutical and Vaccine Production Introduction 11.6.4 Regeneron Pharmaceuticals Revenue in Biopharmaceutical and Vaccine Production Business (2016-2021) 11.6.5 Regeneron Pharmaceuticals Recent Development 11.7 Alexion Pharmaceuticals 11.7.1 Alexion Pharmaceuticals Company Details 11.7.2 Alexion Pharmaceuticals Business Overview 11.7.3 Alexion Pharmaceuticals Biopharmaceutical and Vaccine Production Introduction 11.7.4 Alexion Pharmaceuticals Revenue in Biopharmaceutical and Vaccine Production Business (2016-2021) 11.7.5 Alexion Pharmaceuticals Recent Development 11.8 Johnson and Johnson 11.8.1 Johnson and Johnson Company Details 11.8.2 Johnson and Johnson Business Overview 11.8.3 Johnson and Johnson Biopharmaceutical and Vaccine Production Introduction 11.8.4 Johnson and Johnson Revenue in Biopharmaceutical and Vaccine Production Business (2016-2021) 11.8.5 Johnson and Johnson Recent Development 11.9 GlaxoSmithKline 11.9.1 GlaxoSmithKline Company Details 11.9.2 GlaxoSmithKline Business Overview 11.9.3 GlaxoSmithKline Biopharmaceutical and Vaccine Production Introduction 11.9.4 GlaxoSmithKline Revenue in Biopharmaceutical and Vaccine Production Business (2016-2021) 11.9.5 GlaxoSmithKline Recent Development 11.10 Merck 11.10.1 Merck Company Details 11.10.2 Merck Business Overview 11.10.3 Merck Biopharmaceutical and Vaccine Production Introduction 11.10.4 Merck Revenue in Biopharmaceutical and Vaccine Production Business (2016-2021) 11.10.5 Merck Recent Development 11.11 Lonza 11.11.1 Lonza Company Details 11.11.2 Lonza Business Overview 11.11.3 Lonza Biopharmaceutical and Vaccine Production Introduction 11.11.4 Lonza Revenue in Biopharmaceutical and Vaccine Production Business (2016-2021) 11.11.5 Lonza Recent Development 11.12 FUJIFILM Diosynth Biotechnologies 11.12.1 FUJIFILM Diosynth Biotechnologies Company Details 11.12.2 FUJIFILM Diosynth Biotechnologies Business Overview 11.12.3 FUJIFILM Diosynth Biotechnologies Biopharmaceutical and Vaccine Production Introduction 11.12.4 FUJIFILM Diosynth Biotechnologies Revenue in Biopharmaceutical and Vaccine Production Business (2016-2021) 11.12.5 FUJIFILM Diosynth Biotechnologies Recent Development 12 Analyst's Viewpoints/Conclusions 13 Appendix 13.1 Research Methodology 13.1.1 Methodology/Research Approach 13.1.2 Data Source 13.2 Disclaimer 13.3 Author Details

List of Tables Table 1. Global Biopharmaceutical and Vaccine Production Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027 Table 2. Key Players of Biopharmaceutical Table 3. Key Players of Vaccine Production Table 4. Global Biopharmaceutical and Vaccine Production Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027 Table 5. Global Biopharmaceutical and Vaccine Production Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027 Table 6. Global Biopharmaceutical and Vaccine Production Market Size by Regions (2016-2021) & (US$ Million) Table 7. Global Biopharmaceutical and Vaccine Production Market Share by Regions (2016-2021) Table 8. Global Biopharmaceutical and Vaccine Production Forecasted Market Size by Regions (2022-2027) & (US$ Million) Table 9. Global Biopharmaceutical and Vaccine Production Market Share by Regions (2022-2027) Table 10. Biopharmaceutical and Vaccine Production Market Trends Table 11. Biopharmaceutical and Vaccine Production Market Drivers Table 12. Biopharmaceutical and Vaccine Production Market Challenges Table 13. Biopharmaceutical and Vaccine Production Market Restraints Table 14. Global Biopharmaceutical and Vaccine Production Revenue by Players (2016-2021) & (US$ Million) Table 15. Global Biopharmaceutical and Vaccine Production Market Share by Players (2016-2021) Table 16. Global Top Biopharmaceutical and Vaccine Production Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Biopharmaceutical and Vaccine Production as of 2020) Table 17. Ranking of Global Top Biopharmaceutical and Vaccine Production Companies by Revenue (US$ Million) in 2020 Table 18. Global 5 Largest Players Market Share by Biopharmaceutical and Vaccine Production Revenue (CR5 and HHI) & (2016-2021) Table 19. Key Players Headquarters and Area Served Table 20. Key Players Biopharmaceutical and Vaccine Production Product Solution and Service Table 21. Date of Enter into Biopharmaceutical and Vaccine Production Market Table 22. Mergers & Acquisitions, Expansion Plans Table 23. Global Biopharmaceutical and Vaccine Production Market Size by Type (2016-2021) (US$ Million) Table 24. Global Biopharmaceutical and Vaccine Production Revenue Market Share by Type (2016-2021) Table 25. Global Biopharmaceutical and Vaccine Production Forecasted Market Size by Type (2022-2027) (US$ Million) Table 26. Global Biopharmaceutical and Vaccine Production Revenue Market Share by Type (2022-2027) & (US$ Million) Table 27. Global Biopharmaceutical and Vaccine Production Market Size Share by Application (2016-2021) & (US$ Million) Table 28. Global Biopharmaceutical and Vaccine Production Revenue Market Share by Application (2016-2021) Table 29. Global Biopharmaceutical and Vaccine Production Forecasted Market Size by Application (2022-2027) (US$ Million) Table 30. Global Biopharmaceutical and Vaccine Production Revenue Market Share by Application (2022-2027) & (US$ Million) Table 31. North America Biopharmaceutical and Vaccine Production Market Size by Type (2016-2021) (US$ Million) Table 32. North America Biopharmaceutical and Vaccine Production Market Size by Type (2022-2027) & (US$ Million) Table 33. North America Biopharmaceutical and Vaccine Production Market Size by Application (2016-2021) (US$ Million) Table 34. North America Biopharmaceutical and Vaccine Production Market Size by Application (2022-2027) & (US$ Million) Table 35. North America Biopharmaceutical and Vaccine Production Market Size by Country (2016-2021) & (US$ Million) Table 36. North America Biopharmaceutical and Vaccine Production Market Size by Country (2022-2027) & (US$ Million) Table 37. Europe Biopharmaceutical and Vaccine Production Market Size by Type (2016-2021) (US$ Million) Table 38. Europe Biopharmaceutical and Vaccine Production Market Size by Type (2022-2027) & (US$ Million) Table 39. Europe Biopharmaceutical and Vaccine Production Market Size by Application (2016-2021) (US$ Million) Table 40. Europe Biopharmaceutical and Vaccine Production Market Size by Application (2022-2027) & (US$ Million) Table 41. Europe Biopharmaceutical and Vaccine Production Market Size by Country (2016-2021) & (US$ Million) Table 42. Europe Biopharmaceutical and Vaccine Production Market Size by Country (2022-2027) & (US$ Million) Table 43. Asia-Pacific Biopharmaceutical and Vaccine Production Market Size by Type (2016-2021) (US$ Million) Table 44. Asia-Pacific Biopharmaceutical and Vaccine Production Market Size by Type (2022-2027) & (US$ Million) Table 45. Asia-Pacific Biopharmaceutical and Vaccine Production Market Size by Application (2016-2021) (US$ Million) Table 46. Asia-Pacific Biopharmaceutical and Vaccine Production Market Size by Application (2022-2027) & (US$ Million) Table 47. Asia-Pacific Biopharmaceutical and Vaccine Production Market Size by Region (2016-2021) & (US$ Million) Table 48. Asia-Pacific Biopharmaceutical and Vaccine Production Market Size by Region (2022-2027) & (US$ Million) Table 49. Latin America Biopharmaceutical and Vaccine Production Market Size by Type (2016-2021) (US$ Million) Table 50. Latin America Biopharmaceutical and Vaccine Production Market Size by Type (2022-2027) & (US$ Million) Table 51. Latin America Biopharmaceutical and Vaccine Production Market Size by Application (2016-2021) (US$ Million) Table 52. Latin America Biopharmaceutical and Vaccine Production Market Size by Application (2022-2027) & (US$ Million) Table 53. Latin America Biopharmaceutical and Vaccine Production Market Size by Country (2016-2021) & (US$ Million) Table 54. Latin America Biopharmaceutical and Vaccine Production Market Size by Country (2022-2027) & (US$ Million) Table 55. Middle East & Africa Biopharmaceutical and Vaccine Production Market Size by Type (2016-2021) (US$ Million) Table 56. Middle East & Africa Biopharmaceutical and Vaccine Production Market Size by Type (2022-2027) & (US$ Million) Table 57. Middle East & Africa Biopharmaceutical and Vaccine Production Market Size by Application (2016-2021) (US$ Million) Table 58. Middle East & Africa Biopharmaceutical and Vaccine Production Market Size by Application (2022-2027) & (US$ Million) Table 59. Middle East & Africa Biopharmaceutical and Vaccine Production Market Size by Country (2016-2021) & (US$ Million) Table 60. Middle East & Africa Biopharmaceutical and Vaccine Production Market Size by Country (2022-2027) & (US$ Million) Table 61. Novartis Company Details Table 62. Novartis Business Overview Table 63. Novartis Biopharmaceutical and Vaccine Production Product Table 64. Novartis Revenue in Biopharmaceutical and Vaccine Production Business (2016-2021) & (US$ Million) Table 65. Novartis Recent Development Table 66. Pfizer Company Details Table 67. Pfizer Business Overview Table 68. Pfizer Biopharmaceutical and Vaccine Production Product Table 69. Pfizer Revenue in Biopharmaceutical and Vaccine Production Business (2016-2021) & (US$ Million) Table 70. Pfizer Recent Development Table 71. Sanofi Company Details Table 72. Sanofi Business Overview Table 73. Sanofi Biopharmaceutical and Vaccine Production Product Table 74. Sanofi Revenue in Biopharmaceutical and Vaccine Production Business (2016-2021) & (US$ Million) Table 75. Sanofi Recent Development Table 76. Roche Company Details Table 77. Roche Business Overview Table 78. Roche Biopharmaceutical and Vaccine Production Product Table 79. Roche Revenue in Biopharmaceutical and Vaccine Production Business (2016-2021) & (US$ Million) Table 80. Roche Recent Development Table 81. Abbott Company Details Table 82. Abbott Business Overview Table 83. Abbott Biopharmaceutical and Vaccine Production Product Table 84. Abbott Revenue in Biopharmaceutical and Vaccine Production Business (2016-2021) & (US$ Million) Table 85. Abbott Recent Development Table 86. Regeneron Pharmaceuticals Company Details Table 87. Regeneron Pharmaceuticals Business Overview Table 88. Regeneron Pharmaceuticals Biopharmaceutical and Vaccine Production Product Table 89. Regeneron Pharmaceuticals Revenue in Biopharmaceutical and Vaccine Production Business (2016-2021) & (US$ Million) Table 90. Regeneron Pharmaceuticals Recent Development Table 91. Alexion Pharmaceuticals Company Details Table 92. Alexion Pharmaceuticals Business Overview Table 93. Alexion Pharmaceuticals Biopharmaceutical and Vaccine Production Product Table 94. Alexion Pharmaceuticals Revenue in Biopharmaceutical and Vaccine Production Business (2016-2021) & (US$ Million) Table 95. Alexion Pharmaceuticals Recent Development Table 96. Johnson and Johnson Company Details Table 97. Johnson and Johnson Business Overview Table 98. Johnson and Johnson Revenue in Biopharmaceutical and Vaccine Production Business (2016-2021) & (US$ Million) Table 99. Johnson and Johnson Recent Development Table 100. GlaxoSmithKline Company Details Table 101. GlaxoSmithKline Business Overview Table 102. GlaxoSmithKline Biopharmaceutical and Vaccine Production Product Table 103. GlaxoSmithKline Revenue in Biopharmaceutical and Vaccine Production Business (2016-2021) & (US$ Million) Table 104. GlaxoSmithKline Recent Development Table 105. Merck Company Details Table 106. Merck Business Overview Table 107. Merck Biopharmaceutical and Vaccine Production Product Table 108. Merck Revenue in Biopharmaceutical and Vaccine Production Business (2016-2021) & (US$ Million) Table 109. Merck Recent Development Table 110. Lonza Company Details Table 111. Lonza Business Overview Table 112. Lonza Biopharmaceutical and Vaccine Production Product Table 113. Lonza Revenue in Biopharmaceutical and Vaccine Production Business (2016-2021) & (US$ Million) Table 114. Lonza Recent Development Table 115. FUJIFILM Diosynth Biotechnologies Company Details Table 116. FUJIFILM Diosynth Biotechnologies Business Overview Table 117. FUJIFILM Diosynth Biotechnologies Biopharmaceutical and Vaccine Production Product Table 118. FUJIFILM Diosynth Biotechnologies Revenue in Biopharmaceutical and Vaccine Production Business (2016-2021) & (US$ Million) Table 119. FUJIFILM Diosynth Biotechnologies Recent Development Table 120. Research Programs/Design for This Report Table 121. Key Data Information from Secondary Sources Table 122. Key Data Information from Primary Sources List of Figures Figure 1. Global Biopharmaceutical and Vaccine Production Market Share by Type: 2020 VS 2027 Figure 2. Biopharmaceutical Features Figure 3. Vaccine Production Features Figure 4. Global Biopharmaceutical and Vaccine Production Market Share by Application: 2020 VS 2027 Figure 5. Pharmaceutical Case Studies Figure 6. Biotechnology Case Studies Figure 7. Academic and Research Institutes Case Studies Figure 8. Others Case Studies Figure 9. Biopharmaceutical and Vaccine Production Report Years Considered Figure 10. Global Biopharmaceutical and Vaccine Production Market Size (US$ Million), Year-over-Year: 2016-2027 Figure 11. Global Biopharmaceutical and Vaccine Production Market Size (US$ Million), 2016 VS 2021 VS 2027 Figure 12. Global Biopharmaceutical and Vaccine Production Market Share by Regions: 2020 VS 2027 Figure 13. Global Biopharmaceutical and Vaccine Production Market Share by Regions (2022-2027) Figure 14. Global Biopharmaceutical and Vaccine Production Market Share by Players in 2020 Figure 15. Global Top Biopharmaceutical and Vaccine Production Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Biopharmaceutical and Vaccine Production as of 2020 Figure 16. The Top 10 and 5 Players Market Share by Biopharmaceutical and Vaccine Production Revenue in 2020 Figure 17. Global Biopharmaceutical and Vaccine Production Revenue Market Share by Type (2016-2021) Figure 18. Global Biopharmaceutical and Vaccine Production Revenue Market Share by Type (2022-2027) Figure 19. North America Biopharmaceutical and Vaccine Production Market Size YoY Growth (2016-2027) & (US$ Million) Figure 20. North America Biopharmaceutical and Vaccine Production Market Share by Type (2016-2027) Figure 21. North America Biopharmaceutical and Vaccine Production Market Share by Application (2016-2027) Figure 22. North America Biopharmaceutical and Vaccine Production Market Share by Country (2016-2027) Figure 23. United States Biopharmaceutical and Vaccine Production Market Size YoY Growth (2016-2027) & (US$ Million) Figure 24. Canada Biopharmaceutical and Vaccine Production Market Size YoY Growth (2016-2027) & (US$ Million) Figure 25. Europe Biopharmaceutical and Vaccine Production Market Size YoY Growth (2016-2027) & (US$ Million) Figure 26. Europe Biopharmaceutical and Vaccine Production Market Share by Type (2016-2027) Figure 27. Europe Biopharmaceutical and Vaccine Production Market Share by Application (2016-2027) Figure 28. Europe Biopharmaceutical and Vaccine Production Market Share by Country (2016-2027) Figure 29. Germany Biopharmaceutical and Vaccine Production Market Size YoY Growth (2016-2027) & (US$ Million) Figure 30. France Biopharmaceutical and Vaccine Production Market Size YoY Growth (2016-2027) & (US$ Million) Figure 31. U.K. Biopharmaceutical and Vaccine Production Market Size YoY Growth (2016-2027) & (US$ Million) Figure 32. Italy Biopharmaceutical and Vaccine Production Market Size YoY Growth (2016-2027) & (US$ Million) Figure 33. Russia Biopharmaceutical and Vaccine Production Market Size YoY Growth (2016-2027) & (US$ Million) Figure 34. Nordic Biopharmaceutical and Vaccine Production Market Size YoY Growth (2016-2027) & (US$ Million) Figure 35. Asia-Pacific Biopharmaceutical and Vaccine Production Market Size YoY Growth (2016-2027) & (US$ Million) Figure 36. Asia-Pacific Biopharmaceutical and Vaccine Production Market Share by Type (2016-2027) Figure 37. Asia-Pacific Biopharmaceutical and Vaccine Production Market Share by Application (2016-2027) Figure 38. Asia-Pacific Biopharmaceutical and Vaccine Production Market Share by Region (2016-2027) Figure 39. China Biopharmaceutical and Vaccine Production Market Size YoY Growth (2016-2027) & (US$ Million) Figure 40. Japan Biopharmaceutical and Vaccine Production Market Size YoY Growth (2016-2027) & (US$ Million) Figure 41. South Korea Biopharmaceutical and Vaccine Production Market Size YoY Growth (2016-2027) & (US$ Million) Figure 42. Southeast Asia Biopharmaceutical and Vaccine Production Market Size YoY Growth (2016-2027) & (US$ Million) Figure 43. India Biopharmaceutical and Vaccine Production Market Size YoY Growth (2016-2027) & (US$ Million) Figure 44. Australia Biopharmaceutical and Vaccine Production Market Size YoY Growth (2016-2027) & (US$ Million) Figure 45. Latin America Biopharmaceutical and Vaccine Production Market Size YoY Growth (2016-2027) & (US$ Million) Figure 46. Latin America Biopharmaceutical and Vaccine Production Market Share by Type (2016-2027) Figure 47. Latin America Biopharmaceutical and Vaccine Production Market Share by Application (2016-2027) Figure 48. Latin America Biopharmaceutical and Vaccine Production Market Share by Country (2016-2027) Figure 49. Mexico Biopharmaceutical and Vaccine Production Market Size YoY Growth (2016-2027) & (US$ Million) Figure 50. Brazil Biopharmaceutical and Vaccine Production Market Size YoY Growth (2016-2027) & (US$ Million) Figure 51. Middle East & Africa Biopharmaceutical and Vaccine Production Market Size YoY Growth (2016-2027) & (US$ Million) Figure 52. Middle East & Africa Biopharmaceutical and Vaccine Production Market Share by Type (2016-2027) Figure 53. Middle East & Africa Biopharmaceutical and Vaccine Production Market Share by Application (2016-2027) Figure 54. Middle East & Africa Biopharmaceutical and Vaccine Production Market Share by Country (2016-2027) Figure 55. Turkey Biopharmaceutical and Vaccine Production Market Size YoY Growth (2016-2027) & (US$ Million) Figure 56. Saudi Arabia Biopharmaceutical and Vaccine Production Market Size YoY Growth (2016-2027) & (US$ Million) Figure 57. UAE Biopharmaceutical and Vaccine Production Market Size YoY Growth (2016-2027) & (US$ Million) Figure 58. Novartis Revenue Growth Rate in Biopharmaceutical and Vaccine Production Business (2016-2021) Figure 59. Pfizer Revenue Growth Rate in Biopharmaceutical and Vaccine Production Business (2016-2021) Figure 60. Sanofi Revenue Growth Rate in Biopharmaceutical and Vaccine Production Business (2016-2021) Figure 61. Roche Revenue Growth Rate in Biopharmaceutical and Vaccine Production Business (2016-2021) Figure 62. Abbott Revenue Growth Rate in Biopharmaceutical and Vaccine Production Business (2016-2021) Figure 63. Regeneron Pharmaceuticals Revenue Growth Rate in Biopharmaceutical and Vaccine Production Business (2016-2021) Figure 64. Alexion Pharmaceuticals Revenue Growth Rate in Biopharmaceutical and Vaccine Production Business (2016-2021) Figure 65. Johnson and Johnson Revenue Growth Rate in Biopharmaceutical and Vaccine Production Business (2016-2021) Figure 66. GlaxoSmithKline Revenue Growth Rate in Biopharmaceutical and Vaccine Production Business (2016-2021) Figure 67. Merck Revenue Growth Rate in Biopharmaceutical and Vaccine Production Business (2016-2021) Figure 68. Lonza Revenue Growth Rate in Biopharmaceutical and Vaccine Production Business (2016-2021) Figure 69. FUJIFILM Diosynth Biotechnologies Revenue Growth Rate in Biopharmaceutical and Vaccine Production Business (2016-2021) Figure 70. Bottom-up and Top-down Approaches for This Report Figure 71. Data Triangulation Figure 72. Key Executives Interviewed

Novartis Pfizer Sanofi Roche Abbott Regeneron Pharmaceuticals Alexion Pharmaceuticals Johnson and Johnson GlaxoSmithKline Merck Lonza FUJIFILM Diosynth Biotechnologies